News Quantified

ICAD – icad inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

iCAD, Inc. (NASDAQ: ICAD) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.

iCAD, Inc. (NASDAQ: ICAD) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.

iCAD Reports Financial Results for Third Quarter Ended September 30, 2024

iCAD's ProFound Detection Version 4.0 Gains FDA Clearance

iCAD to Attend 15th Annual Craig-Hallum Alpha Select Conference

Form 10-Q ICAD INC For: Sep 30

Form 8-K ICAD INC For: Nov 13

Top News Gainers

4/23 iCAD Announces Pricing of $12.5 Million Registered Direct Offering 28.5%

2/27 Q4/2019 12/31/2019 EPS -0.100 ZacksConsensus -0.120 ActVsEst 0.020 - Beat 22.1%

2/13 iCAD to Report Fourth Quarter 2019 Financial Results on Thursday, February 27, 2020 12.0%

2/11 First Brain Tumor Treated with Xoft IORT in the United States 8.1%

7/10 SimonMed Imaging Implements the First FDA-Cleared 3D Tomosynthesis Software Using Artificial Intelligence 7.5%

8/1 Q2/2019 6/30/2019 EPS -0.090 ZacksConsensus -0.100 ActVsEst 0.010 - Beat 7.2%

1/15 Form 3 ICAD INC For: Jan 13 Filed by: Klein Michael S 6.9%

9/10 iCAD’s ProFound AI Reader Study Published in Radiology: Artificial Intelligence 6.3%

6/13 iCAD Introduces ProFound AI™ for 2D Mammography in Europe 5.4%

4/28 iCAD Inc (NASDAQ: ICAD) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 5.3%

Top News Decliners

3/11 Form 10-K ICAD INC For: Dec 31 -17.2%

8/3 iCAD's (ICAD) CEO Michael Klein on Q2 2019 Results - Earnings Call Transcript [Seeking Alpha] -11.3%

3/31 iCAD Announces New Credit Facility with Bridge Bank, Increasing Operational Flexibility -10.9%

7/11 iCAD’s ProFound AI™ for 2D Mammography Receives CE Mark Approval -9.3%

10/30 Q3/2019 9/30/2019 EPS -0.100 ZacksConsensus -0.100 ActVsEst 0.000 - In-Line -7.3%

5/15 Form 10-Q ICAD INC For: Mar 31 -5.9%

10/1 iCAD Showcases ProFound AI™ Platform at European Society of Breast Imaging Annual Scientific Meeting in Budapest -5.1%

10/1 iCAD Inc (NASDAQ: ICAD) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -4.2%

3/23 iCAD Launches New Initiatives Leveraging Unique Capabilities of its Robust Product Portfolio to Reduce Health Care System Pressures During the COVID-19 Pandemic -4.0%

6/7 iCAD Inc (NASDAQ: ICAD) was upgraded by analysts at ValuEngine from a "buy" rating to a "strong-buy" rating. -3.9%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day